iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | Sustainability & Chart
ISIN:
WKN:
IE00BDZVHG35
A2JDYM
ISIN:
IE00BDZVHG35
WKN:
A2JDYM
Basic information on the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Index
NASDAQ Biotechnology NET Index
Provider
iShares
Asset Class
Stocks
Total Expense Ratio (TER)
0,35%
Fund Volume
$ 1 billion
Positions
254
Top 10 Weight
43,62%
Distribution Policy
Distributing
Replication Method
Physical
Launch Date
05.03.2018
Fund Currency
USD
As of: 21.08.2026
Overall Impact Performance
based on companies in this ETF
Climate
Society
Gender
Impact Score
Description iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) provides exposure to U.S. biotechnology companies, tracking the performance of the Nasdaq Biotechnology Index. The fund focuses primarily on firms involved in the research, development, and manufacturing of therapeutic treatments and pharmaceutical products.iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) Sustainability Performance
Climate
Society
Gender
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of the ETF based on the weighted average values of companies in the ETF. Each position is included in the overall assessment according to its share in the ETF.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). The ETF evaluation is based on 67.27% of the total ETF volume. In principle, equities and corporate bonds can be evaluated. Other asset classes or positions without available sustainability data were not taken into account. Learn more about our method.
Positions
Name | Weight | Country | Industry | Climate | Society | Gender | Impact Score |
|---|
Die größten 10 Positionen des iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) machen 43.62 % des gesamten Fondsvolumens aus.
Stand: 21.08.2026
Compare iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) with ...
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
?
Impact Score
Climate
Society
Gender
Find more sustainable ETFs
© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev